~~<i id='EC91951210'><strike id='EC91951210'><tt id='EC91951210'><pre id='EC91951210'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

knowledge

author：explore 2025-09-29 22:52:40 - browse：46289

People taking notes while sitting around a meeting table — Adobe

It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： International team creates first chimeric human

hotspot

knowledge

leisure time

explore

leisure time

ApackofR.J.Reynolds'newCamelCrushcigarettesforsaleinCaliforniaNicholasFlorko/STATWASHINGTON–Tobaccog

WSS

As AI in medicine takes off, can 'human in the loop' prevent harm?

Kenai launches with $82 million for Parkinson’s stem cell therapy

In search for therapies for solid tumors, companies turn to claudin

As AI in medicine takes off, can 'human in the loop' prevent harm?

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

focus

knowledge

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

FDA advisers back CAR

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: Bristol, Sangamo, Gilead, and more

The cancer drug shortage isn’t new — and neither are the solutions

FDA advisers back CAR

Psychedelics group wrestles with new pharma identity

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Bright Health sells Medicare Advantage business to Molina

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

hotspot

How to address the problem of discarded donor organs

UCLA team creates talking throat patch for voice disorders

Steward Health Care Massachusetts hospitals face fiscal disaster

House looks to weaken Medicare negotiation

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Steward Health Care Massachusetts hospitals face fiscal disaster

knowledge

leisure time

explore

leisure time